Anthraquinone derivativePhase 3 trialInvestigational

Vosaroxin

How it works

Interferes with DNA replication and transcription, leading to cell death in leukemia cells.

Cancer types

Leukemia— Acute myeloid leukemia (AML)

Efficacy

In clinical trials, around 30% of AML patients achieved an objective response, with a median overall survival of approximately 5 months.

Side effects

Severe

This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.

This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.